GMP Cytokines Market to Outstrip $158.13 Million by 2027 Growing Sturdy at 8.1% CAGR – COVID-19 Impact and Global Analysis by TheInsightPartners.com

NEXT STORY
New study to monitor COVID-19 illness and vaccine safety, effectiveness in children and youth in Canada
PREV STORY
Sorrento Announces Clinical Research Agreement With Mayo Clinic and FDA Clearance for the First Phase 1b Pilot Study Using Sofusa Lymphatic Drug Delivery Technology to Deliver Ipilimumab in Patients With Melanoma
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Inovio Pharmaceuticals Reports 2016 Fourth Quarter and Year End Financial Results

PLYMOUTH MEETING, Pa., March 15, 2017 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today ...

author_avatar
NASDAQ Market News

XOMA Presents Positive Data from PTH1R Monoclonal Antibody Program

BERKELEY, Calif., April 18, 2017 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq:XOMA), a pioneer in ...

author_avatar
NASDAQ Market News

At 10.00% CAGR, Global Point Of Care Diagnostics Market Will Reach $40.50 Bn by 2022

Sarasota, FL, July 13, 2017 (GLOBE NEWSWIRE) -- Zion Market Research has published a ...

author_avatar
NASDAQ Market News